Cargando…

Development of a Severity Classification System for Sickle Cell Disease

PURPOSE: There is no well-accepted classification system of overall sickle cell disease (SCD) severity. We sought to develop a system that could be tested as a clinical outcome predictor. PATIENTS AND METHODS: Using validated methodology (RAND/UCLA modified Delphi panel), 10 multi-disciplinary exper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Nirmish, Beenhouwer, David, Broder, Michael S, Bronte-Hall, Lanetta, De Castro, Laura M, Gibbs, Sarah N, Gordeuk, Victor R, Kanter, Julie, Klings, Elizabeth S, Lipato, Thokozeni, Manwani, Deepa, Scullin, Brigid, Yermilov, Irina, Smith, Wally R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604906/ https://www.ncbi.nlm.nih.gov/pubmed/33149635 http://dx.doi.org/10.2147/CEOR.S276121

Ejemplares similares

Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe
por: Ferlis, Mica, et al.
Publicado: (2022)

COVID Symptoms and COVID Anxiety in Sickle Cell Disease
por: Smith, Wally R, et al.
Publicado: (2020)

Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease
por: Sop, Daniel M., et al.
Publicado: (2022)

Developing an emergency department order set to treat acute pain in sickle cell disease
por: Duroseau, Yves, et al.
Publicado: (2021)

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2020)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
por: Minniti, Caterina P., et al.
Publicado: (2021)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022)

An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19
por: Broder, Michael S, et al.
Publicado: (2022)

Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium
por: Masese, Rita V., et al.
Publicado: (2021)

MSR10 An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19
por: Broder, M, et al.
Publicado: (2022)

Iron Overload in Sickle Cell Disease
por: Raghupathy, Radha, et al.
Publicado: (2010)

5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
por: Kanter, J., et al.
Publicado: (2023)

Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021)

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
por: Achebe, M, et al.
Publicado: (2022)

The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
por: Rizio, Avery A., et al.
Publicado: (2020)

Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry
por: Glassberg, Jeffrey A., et al.
Publicado: (2020)

PI-01: GRNDAD AND COUSIN: INVESTIGATOR-INITIATED COLLABORATIONS TO IMPROVE CARE IN SICKLE CELL DISEASE
por: J., LITTLE, et al.
Publicado: (2022)

Sickle cell disease: wheeze or asthma?
por: Cohen, Robyn T., et al.
Publicado: (2015)

Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors
por: Han, Xue, et al.
Publicado: (2021)

Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
por: Klings, Elizabeth S, et al.
Publicado: (2001)

Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method
por: Cuker, Adam, et al.
Publicado: (2020)

2396. Clostridium difficile Infection is Children with Sickle Cell Disease: An Uncommon Entity
por: Lee, Philip, et al.
Publicado: (2019)

Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease
por: Howell, Kristen E., et al.
Publicado: (2023)

Altered parasite life-cycle processes characterize Babesia divergens infection in human sickle cell anemia
por: Cursino-Santos, Jeny R., et al.
Publicado: (2019)

An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model
por: Treadwell, Marsha J., et al.
Publicado: (2022)

Common Complications of Sickle Cell Disease: A Simulation-Based Curriculum
por: Cramer-Bour, Cassondra, et al.
Publicado: (2021)

Perspectives of individuals with sickle cell disease on barriers to care
por: Phillips, Shannon, et al.
Publicado: (2022)

Earlier Versus Later Augmentation with an Antipsychotic Medication in Patients with Major Depressive Disorder Demonstrating Inadequate Efficacy in Response to Antidepressants: A Retrospective Analysis of US Claims Data
por: Yermilov, Irina, et al.
Publicado: (2018)

Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2023)

Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 - a fifteen hospital observational study in the Bronx, New York
por: Hoogenboom, Wouter S., et al.
Publicado: (2021)

Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study
por: Badawy, Sherif M, et al.
Publicado: (2021)

Ambulatory Hypertension in Pediatric Patients With Sickle Cell Disease and Its Association With End-Organ Damage
por: Ranabothu, Saritha, et al.
Publicado: (2020)

Sickle cell disease complications: Prevalence and resource utilization
por: Shah, Nirmish, et al.
Publicado: (2019)

Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study
por: Green, Nancy S., et al.
Publicado: (2020)

S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD)
por: Kanter, J, et al.
Publicado: (2022)

The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
por: Greene, Nupur, et al.
Publicado: (2022)

Precision, integrative medicine for pain management in sickle cell disease
por: Smith, Wally R., et al.
Publicado: (2023)

Time to rethink haemoglobin threshold guidelines in sickle cell disease
por: Ballas, Samir K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_35q57odpid9u2aaml1mjhlggbh